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ABSTRACT 
Adverse reproductive health outcomes, such as pelvic inflammatory disease, ectopic 
pregnancy, and tubal factor infertility, have been associated with Chlamydia trachomatis and 
Neisseria gonorrhoea infections. We propose that these reproductive health outcomes could 
be complemented by measuring subsequent pregnancies and assisted reproductive technologies 
to assess impact on fertility. The study design was a cohort study of women in Queensland 
(QLD), Australia, using data linkage methods to link chlamydia and/or gonorrhea testing 
records (including an unexposed group undergoing full blood count tests) (2000 and 2005) 
with the QLD Perinatal Registry (2000 to 2013). We used generalised additive modelling to 
determine the associations of chlamydia and/or gonorrhea testing history (and test results) with 
odds of subsequent pregnancy in comparison to the unexposed group. The cohort included 132 
962 women, with 69 533 records of pregnancies. Women in the exposed group, with no prior 
pregnancy, had a reduced odds of a pregnancy than the unexposed group during the follow up 
of the study (20 year old (at 2005) aOR 0.91 95% CI 0.87-0.95, and 25 year old aOR 0.71 95% 
CI 0.68-0.75).  Our data provides further evidence at a population level of the significant impact 
on reproductive outcomes associated with chlamydia and gonorrhea.  
  
INTRODUCTION  
Chlamydia trachomatis (chlamydia) and Neisseria gonorrhoeae (gonorrhea) are commonly 
diagnosed sexually transmitted infections (STI) that have been associated with serious 
reproductive health outcomes for women, and may cause obstetric or perinatal complications 
(Menon et al., 2015, Lenz & Dillard, 2018). Obstetric or perinatal complications associated 
with STIs during pregnancy include preterm deliveries, preterm rupture of membranes, low 
birth weight, or still birth (Liu et al., 2013, Heumann et al., 2017, Reekie et al., 2018). Tubal 
factor infertility and ectopic pregnancy have been associated with a history both STIs in 
numerous studies (Swasdio et al., 1996, Hillis et al., 1997, Barlow et al., 2001, Bakken et al., 
2007, Goller et al., 2018, Reekie et al., 2019). Pelvic Inflammatory Disease (PID) has been 
strongly associated with both pathogens, and PID in turn increases the risk of ectopic 
pregnancy and tubal factor infertility (TFI) (Westr¨om et al., 1992, Hillis et al., 1997, Low et 
al., 2006, Simms et al., 2006, Bakken & Ghaderi, 2009, Oakeshott et al., 2010, Davies et al., 
2013, Davies et al., 2014, Reekie et al., 2014, Reekie et al., 2018). Population level 
assessments, typically using data linkage approaches, have robustly established chlamydia and 
gonorrhea testing to be significant risk factor(s) for PID, even for some studies where test 
results have been negative (Davies et al., 2013, Davies et al., 2014, Reekie et al., 2014, Davies 
et al., 2018, Reekie et al., 2018). However, PID is not a notifiable condition, diagnosis is 
subjective and may be inconsistent between different settings (Goller et al., 2019).  
 
In spite of the substantial proof for these reproductive health burdens, there is limited evidence 
evaluating subsequent pregnancy, which has been substantiated with a birth record, as an 
indicator of fertility after chlamydia or gonorrhea infections. We are aware of only one previous 
study that has evaluated pregnancy (as a measure of fertility), substantiated by a birth record, 
and associated with a history of chlamydia testing. This was a study of a Norwegian population 
(n=20 762) that found no difference in odds of a pregnancy associated with chlamydial testing 
results (Bakken et al., 2007). However, this study does not provide a comparison to an 
unexposed group who were not tested for chlamydia (Bakken et al., 2007). Robust measure of 
pregnancy that has been substantiated by a birth record as an outcome measure would add to 
current understanding of the reproductive health burden from these STIs. We have used 
retrospective cohort study design to evaluate the association of pregnancy (via birth records) 
and perinatal outcomes (pre-term or low birth weight and still birth) with chlamydia and/or 
gonorrhea testing history and test results in women in the State of Queensland, Australia.    
 
METHODS 
Study design and data retrieval 
 
We used a cohort study to investigate associations with chlamydia and gonorrhea testing 
history and pregnancy outcomes (using retrospective data linkage methodologies). The datasets 
used are based in the State of Queensland, Australia (~20% of Australian population). Our 
primary outcome was pregnancy defined as a record of birth in the Queensland Perinatal 
Registry. We used the birth record to define pregnancy because this provided a substantiated 
measure that a pregnancy had occurred. Secondary outcomes included perinatal outcomes of 
low birth weight (<2500g) and pre-term birth (before 37 weeks). Secondary outcomes were 
derived from the Queensland Perinatal Registry, and so analysis for these outcomes was 
restricted to women with a birth record (pregnancy). 
 
We compiled the cohort by merging two datasets that we obtained from AUSLAB, the 
Queensland Health Clinical and Scientific Information System. Our cohort included two 
groups of women: 1) an exposed group that comprised women who had had a chlamydia or 
gonorrhea test between 2000 and 2005; and 2) an unexposed group that comprised women who 
had a full blood count laboratory investigation but no chlamydia and/or gonorrhea test between 
2000 and 2005. Records of tests for chlamydia and/or gonorrhea, conducted in all public 
pathology laboratories in QLD between January 1st, 2000 and December 31st 2005 for women 
aged between 15 and 31 were collated (Median age 24; IQR 21 – 26, at Dec 31st 2005). The 
unexposed group comprised women aged 15-31 years old (Median age 24; IQR 21 – 27, at Dec 
31st 2005) who underwent a full blood count test (independent of indications for the test) in the 
same five year period and with no record of testing for chlamydia and/or gonorrhea during the 
study period (Figure 1). Entry into the exposed group was defined as having any testing history 
to chlamydia and/or gonorrhea, as women who access testing services have characteristics that 
are more likely to result in a positive diagnosis. Previous studies using PID as an outcome 
measure have also found that women with a testing history, but no positive diagnosis 
experience increased risk of PID (Reekie et al., 2018). Further analysis also was used to 
compare women in the exposed group by their diagnosis results, by classification into distinct 
groups based on testing status (negative or positive) and number of tests. Full blood count was 
selected as our unexposed because these were women who were also in contact with primary 
care and also did not have a test record in our data for chlamydia and/or gonorrhea. The FBC 
has a range of indications, but both FBC and STI screening can be used during antenatal or 
preparation for pregnancy investigations, therefore, analysis also included pregnancy during 
the testing window (Troussard et al., 2014). Deterministic methods were used to remove any 
women from the full blood count group that also appeared in the chlamydia and/or gonorrhea 
testing dataset.   
 
We linked the testing dataset with the Perinatal Data Collection (Queensland Health Statistics 
Unit) that records all births in Queensland. The perinatal dataset included all birth entries from 
01/01/2000 until 30/06/2013. The perinatal data included the mother’s date of birth, the baby’s 
date of birth, birth weight, gestational weeks of the pregnancy, and stillbirth.  
 
< Figure 1 goes here > 
Linkage methodologies 
First name, middle name (if available), surname, sex, and date of birth were used for linking 
the AUSLAB datasets with the Queensland Perinatal Registry. Linkage was deterministic in 
the case when information matched exactly, and probabilistic methods were used in the 
remaining cases. The linkage framework does not have a published error rate, but has a similar 
design to the Western Australia and New South Wales systems which have reported error rates 
of 0.11% and 0.3% respectively (New South Wales Government, 2012, Queensland 
Government, 2017). Women whose data were unable to be linked with the Queensland 
Perinatal Registry were assumed to have no births during the study time frame. Multiple 
linkages (n=2702) were randomly assigned a single linkage in the dataset (Supplemental Data 
S1 and Supplementary Figure S1). Women with missing postcode information (n=19764), or 
a postcode from outside of Queensland were removed (n=4525). Thirty women without a date 
of birth were excluded. All women with a recorded birth that occurred before the test record 
during the 2000-2005 test were excluded. All person-records were assigned a de-identified 
code and the data were provided to the study investigators after linkage and de-identification.  
 
Statistical Methods 
We used generalised additive modelling to determine the association between chlamydia 
and/or gonorrhea testing history (and test results) and each outcome. Information about the 
testing dates for women in the unexposed group, and women with only a negative test result 
was not available, which restricted any valid time-to-event analysis. Analysis assessed the odds 
of pregnancy in a discrete outcome period. Age was modelled with a restricted cubic spline 
with three knots and interacted with pregnancy in the testing period and exposure status, in 
order to evaluate the impact of association as a function of follow-up time relative to age. 
Models were adjusted for age, pregnancy in the testing period, socioeconomic status, and 
location (a measure of access to health services (Welfare, 2019)). Entry into the cohort was 
based on testing records in AUSLAB (either chlamydia and/or gonorrhea test [exposed] or 
blood test [unexposed]) in 2000 to 2005. The cohort was followed up to assess for birth and 
secondary outcomes (birth weeks, birth weight) until 30/06/2013. The study analysed only the 
first recorded birth for each woman. We converted birthweight (± 2500g) and birth weeks (± 
37 weeks) to binary outcomes for the purposes of this study, using values from World Health 
Organisation standards [10]. Postcodes were used to classify the socio-economic area of the 
women, defined as low, middle or high using the ABS Index of Relative Socio-economic 
Disadvantage, and to classify regionality as living in a major city, regional or remote 
geographical area (Statistics, 2005). If a woman had multiple testing events the first postcode 
recorded was used. Location was then defined as the combination of socioeconomic status and 
regionality, to account for the interaction effect between an area’s socioeconomic status and 
overall access to health services. 
Data preparation and analysis was completed using the R software version 3.6.3. The code 
used for this analysis can be found at github.com/torricallan/QLDPregnancyStudy. 
 
Ethical approval 
This study was reviewed and approved by the Metro North Hospital and Health Service Human 





The cohort comprised 132 962 women after linkage, refinement, and exclusions (Figure 1, 
Supplementary Table S1). The women in the cohort were aged between 22 and 39 years at the 
study completion, June 30th 2013, (Median 31; IQR 28-34). Overall, 24 702 (18.6%) women 
were tested for chlamydia and/or gonorrhea (exposed), including, 20 871 (15.7%) women who 
had only negative tests(s), 3 237 (2.4%) who had a single positive test recorded, and 594 (0.4%) 
who had multiple positive tests recorded. The unexposed group included 108 260 women. A 
total of 69 533 (52.3%) women in the cohort had a pregnancy during the study time frame 
(Figure 1). A total of 37 495 (28.1%) women in the cohort had a pregnancy during the testing 
window (2000-2005), and 43 325 (32.5%) had a pregnancy during the outcome period (2006-
2013).  
 
<Figure 2 goes here> 
 
Women in the exposed group with no prior pregnancy in the testing period (2000-2005) had 
varying odds of having a pregnancy depending on their age at the end of the outcome period 
(Figure 2). Younger women (aged 20 in 2005, no pregnancy during testing window) had 
slightly reduced odds of pregnancy in the outcome window compared to same women in the 
unexposed group (aOR 0.91; 95% CI 0.87 – 0.95), whereas the reduction in the chances of 
having a pregnancy for women aged 25 in 2005 was larger (aOR 0.71; 95% CI 0.68 – 0.75) 
(Table 1). 
 
<Table 1 goes here> 
 
When investigating the association between the classification of tests within the exposure 
group and pregnancy, we found that women with all negative tests had reduced odds of 
pregnancy compared to women with a single positive test when they were aged 20 in 2005 and 
had no pregnancy in the testing period. However, for women that were older at the end of the 
testing period, there was no discernible distinction to be made between women with a single 
positive test and women with all negative tests. Women with multiple positive tests had 
chances of pregnancy in the outcome window that were comparable with women in the 
unexposed group. The association between the type of the infection for women with a positive 
test (chlamydia only, gonorrhea only, chlamydia and gonorrhea) showed that women aged 25 
with no pregnancy in the testing period, had reduced odds of pregnancy in the outcome window 
if they tested positive for chlamydia (aOR 0.70; 95% CI 0.62 – 0.79). The odds ratio for women 
testing positive for gonorrhea in this group was higher and the confidence interval was wide 
(aOR 0.78; 95% CI 0.50 – 1.21). Women with positive results for both pathogens were 
comparable to all women in the exposed group, and the odds of pregnancy was influenced by 
age (Figure 3, Table 2). 
 
<Figure 3 goes here> 
 
Amongst women with a pregnancy in the testing period, women in the exposed group had 
increased odds of having a pregnancy in the outcome window. This difference was most 
pronounced for younger women. Women with a pregnancy in the testing period also had 
increased chances of a pregnancy in the outcome window if they had a single positive test 
compared to all negative tests (Figure 2), and greater chances again if they had multiple positive 
tests. Women with a pregnancy during the testing window that had a gonococcal infection had 
increased chances of pregnancy in the outcome window compared to women with a chlamydial 
infection. 
 
<Table 2 goes here> 
The women who had a history of chlamydia and /or gonorrhea testing were more likely to have 
adverse perinatal outcomes such as low birth weight and pre-term birth (Table 2). Women with 
multiple positive tests had significantly higher odds of the low birth weight outcome compared 
to women with single positive tests and all negative tests. The odds of pre-term birth were 
comparable between all testing groups.   
 
DISCUSSION 
In a study of 132 962 women in Queensland, Australia, we have measured the reproductive 
outcomes for women with a history of testing for chlamydia and gonorrhea. We have 
investigated how future pregnancies depend on the presence or absence of a testing history, the 
number of tests, the diagnosis of these tests, and the infection. We have also shown that the 
association between testing history and odds of future pregnancy is dependent on the age at 
which women are exposed to a test, and if they had any pregnancy during the same time frame 
as their testing history. This is the first large study using data-linkage to test an association of 
any recorded subsequent pregnancy with a history of testing for these two STIs. 
 
A strength of our study is the large sample size, an order of magnitude larger than the only 
other study to look at subsequent pregnancy as an outcome measure (Bakken et al., 2007), and 
is a similar order of magnitude to studies that have established the association of chlamydial 
testing history with PID (Low et al., 2006, Bakken & Ghaderi, 2009, Davies et al., 2016, 
Reekie et al., 2018) and tubal factor infertility (Reekie et al., 2019). A further strength of our 
study is the inclusion of both chlamydia and gonorrhea, and an unexposed group, unlike the 
only prior study to test for the association with infertility by measuring subsequent pregnancies. 
Women in the exposed group had reduced odds of pregnancy compared to the unexposed 
group, when they had no prior pregnancy in the testing period, and they were aged within the 
middle of the distribution of ages at the end of the testing period. 
 
There are limitations of our study that should be considered.  The timeframe of the cohort did 
not cover full reproductive years for the women, although it did extend beyond the median age 
of first birth in QLD in 2013 (28.5; (Statistics, 2013)) as the cohort median of age 31 (IQR 28-
34) at study completion. There were 50 185 notifications of chlamydial and gonococcal 
infections in Queensland from 2000-2005 (including all ages and genders) (Health, 2019), so 
our data represents ~12% of all infections in this time period for this state.  We were unable to 
account for people who had moved out of the study area prior to pregnancies although 2005 
census data reported limited migration out of the state so we expect this to have only a small 
impact (Statistics, 2005).  We have adjusted for location and socioeconomic status, however, 
these factors still may be over-represented in the exposed (tested) group relative to the 
unexposed group. Relying solely on pathology data and the few associated demographic details 
means we have no information regarding behavioral and lifestyle predictors of those 
undergoing STI testing, which risks further confounding of results and difficult interpretation. 
Further, we were unable to assess the physicians' decision-making process when identifying 
women for testing, and therefore not able to account for the significance of provider-initiated 
testing as opposed to patient-initiated testing. It is also possible that women recorded in the 
perinatal database (which covers both public and private hospitals) may have had chlamydia 
and gonorrhea tests not recorded in the AUSLAB dataset (government funded testing only).  
The unexposed group selection was for women who had full blood count test done but no 
chlamydia and gonorrhea test recorded in AUSLAB. Without knowledge as to why these 
women were tested, this raises the possibility of further selection bias. The study data did not 
include dates of tests, or all incidences of negative tests, preventing a temporal analysis that 
may have provided a richer understanding of the findings. 
 
A previous analysis of population characteristics has established that women who access 
testing services for chlamydia have lower condom usage and higher numbers of sexual 
partners, and that these characteristics were more likely to result in chlamydia positivity for 
women with a testing history compared to a general population (Riha J, 2011). Our findings 
suggest that STI testing may be indicative of risk behaviors that may predispose individuals to 
infection and consequently greater adverse outcomes. Care must be taken in interpreting our 
results to determine the exact reproductive burden of these two STIs, as our definition of 
exposure implies that women in the exposed group are more sexually active and potentially 
more likely to have a pregnancy than women in the unexposed group. The youngest women in 
our data had comparable odds of pregnancy between exposed and unexposed groups, however 
older women in the exposed group had reduced odds. Similarly, younger women with a single 
positive test had higher chances of pregnancy compared to women with all negative tests. 
However, there was no distinction between the two for older women. Women with multiple 
positive tests, women with both chlamydia and gonorrhea infections, and women with a testing 
history that had a pregnancy in the testing window were more likely to have a pregnancy in the 
outcome window. However, it is important to consider these results in the light of the known 
differences in health outcomes and STI incidences for Indigenous Australians. The data on 
Indigenous identity was not available for the unexposed group and is likely to be a confounding 
factor that has particularly contributed to the increased odds of pregnancy results for multiple 
infections, especially as indigenous women are more likely to test positive to chlamydia and 
gonorrhea, and more likely to have younger pregnancies (Graham et al., 2012, Utz, 2014).   
Women in the exposed group had increased odds of pre-term births and low birth-weight 
outcomes. Further, women with a single positive test had odds ratio of both outcomes that were 
greater than the comparable estimates for women with all negative tests. Although the 95% 
Confidence Intervals do overlap, this supports the increased reproductive burden of a positive 
test diagnosis, in comparison to only negative tests, as it agrees with previous findings using 
outcomes of PID and tubal factor infertility (Davies et al., 2013, Davies et al., 2014, Reekie et 
al., 2014, Davies et al., 2018, Reekie et al., 2018).  
 
CONCLUSION  
We report a relationship between a history of chlamydia or gonorrhea testing history in women 
with reduced odds of having a subsequent pregnancy indicating that these two infections 
continue to represent a reproductive health burden.  
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Figure 1. Summary of cohort. The cohort was formed using data linkage methodologies 
between a testing dataset and perinatal dataset as outlined in the figure. 
Figure 2. Cohort Summary. (A) The distribution of ages grouped by exposure group (B-D) 
Comparison of the 1st percentile, median and 9th percentile values for the age distribution for 
exposure groups (E) Proportion of the cohort in each location and SES category by exposure 
(F) Proportion of the cohort with a pregnancy in the testing period by exposure. 
Figure 3: Association of chlamydia and gonorrhea testing and pregnancy. (A) Compares 
exposed and unexposed group (B) Compares single positive test, all negative tests and 
unexposed group (C) Compares Chlamydia positive, Gonorrhea positive and unexposed group. 
All lines represent the predicted probability of having a pregnancy in the outcome period, and 
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Figure 3: Association of chlamydia and gonorrhea testing and pregnancy. (A) Compares 
exposed and unexposed group (B) Compares single positive test, all negative tests and 
unexposed group (C) Compares Chlamydia positive, Gonorrhea positive and unexposed group. 
All lines represent the predicted probability of having a pregnancy in the outcome period, and 
the shaded area represents the (endpoint transformed) 95% confidence interval. 
Table 1: Odds ratios of pregnancy in the outcome period. 
  aORa (95% CI)  aOR (95% CI)  aOR (95% CI) 
Not Pregnant in the testing period 




(n = 20, 
250) 
0.91 (0.87, 0.95) Multiple Positive Tests 
(n = 468) 
 
1.51 (1.20 , 1.90)   
 
CT (n = 
2,500) 
1.08 (0.98, 1.20) 
Single Positive Test (n = 
2,756) 
 
1.07 (0.97, 1.17) 
 
NG (n = 
171) 
1.06 (0.71, 1.59) 
All Negative Tests (n = 
17,026) 
0.86 (0.82, 0.90) CT/NG (n = 
553) 
1.35 (1.11, 1.65) 
Aged 25  0.71 (0.68, 0.75)   Multiple Positive Tests 
 
1.04 (0.81, 1.35) CT 0.70 (0.62, 0.79) 
Single Positive Test 
 
0.66 (0.59, 0.75) NG 0.78 (0.50, 1.21) 
All Negative Tests 0.72 (0.68, 0.75) CT/NG 0.81 (0.63, 1.04) 
Aged 30  0.87 (0.79, 0.95)   Multiple Positive Tests 
 
0.90 (0.40, 2.03) CT 1.01 (0.76, 1.36) 
Single Positive Test 
 
1.00 (0.76, 1.31) NG 0.69 (0.30, 1.60) 
All Negative Tests 0.87 (0.78, 0.96) CT/NG 0.91 (0.43, 1.93) 
 Unexposed 
(n = 75, 
217) 
1 (ref) Unexposed 1 (ref) Unexposed 1 (ref) 
       
       
Pregnant in the testing period 




(n = 4,452) 
1.72 (1.59, 1.86) Multiple Positive Tests 
(n = 126) 
 
4.17 (2.72, 6.40) CT (n = 463) 2.53 (2.06, 3.11) 
Single Positive Test (n = 
481) 
 
2.85 (2.33, 3.40) NG (n = 27) 6.17 (2.47, 15.40) 
All Negative Tests (n = 
3,845) 
1.53 (1.40, 1.67) CT/NG (n = 
117) 
6.13 (3.92, 9.59) 
Aged 25  1.35 (1.26, 1.45) Multiple Positive Tests 
 
2.89 (1.97, 4.24) CT 1.64 (1.35, 1.99) 
Single Positive Test 
 
1.77  (1.47, 2.15) NG 4.53 (1.84, 11.14) 
All Negative Tests 1.28 (1.19, 1.38) CT/NG 3.66 (2.43, 5.51) 
Aged 30  1.64 (1.48, 1.83) Multiple Positive Tests 
 
2.50 (1.07, 5.83) CT 2.37 (1.70, 3.31) 
Single Positive Test 
 
2.67 (1.95, 3.65)      NG 3.99 (1.38, 11.60) 




1 (ref) Unexposed 1 (ref) Unexposed 1 (ref) 
a  All models are adjusted for location and pregnancy in the testing period interacted with a cubic spline of age evaluated at 20, 25, and 30 (as at 
2005)  
b Any history of testing for chlamydia/gonorrhea
Table 2: Perinatal Outcomes associated with a history of STI testing and test results 
 aORa (95% CI)  aOR (95% CI) 
Pre-Term Birth 
Exposedb (n = 8,144) 1.28 (1.18, 1.39) Multiple Positive Tests (n = 290) 
 
1.21 (0.81, 1.81) 
Single Positive Test (n = 1,202) 
 
1.37 (1.14, 1.66) 
All Negative Tests (n = 6,652) 1.27 (1.16, 1.39) 
Low Birth Weight 
Exposed 1.35 (1.23, 1.48) Multiple Positive Tests 
 
2.61 (1.85, 3.69) 
Single Positive Test 
 
1.50 (1.23, 1.84) 
All Negative Tests 1.29 (1.17, 1.43) 
a Models adjusted for presence of the outcome (pre-term birth or low birth weight) in the testing period, a cubic 
spline of age (at 2005) with 3 knots, mother’s age at birth and location 
b Any history of testing for chlamydia/gonorrhea 
 
